Bayer Monsanto merger

By Dr Vandana Shiva

On 7.1.2018 the Competition Commission of India(CCI), India’s anti-trust body for preventing monopoly,invited comments from the public on the adverse impacts of the Bayer-Monsanto merger. I submitted my objections on the Bayer Monsanto merger to CCI on January 20 2018. There are many reasons why the merger must not be allowed.